Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Qiongli, Su"'
Publikováno v:
In Clinical eHealth December 2023 6:144-146
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Bladder cancer is the most common cancer of the urinary system. Bladder urothelial cancer accounts for 90% of bladder cancer. These two cancers have high morbidity and mortality rates worldwide. The identification of biomarkers for bladder cancer and
Externí odkaz:
https://doaj.org/article/5c93bf548dcd4841a56fb04d1209c6bb
Autor:
Haifang Du, Ting Tao, Simeng Xu, Changqiong Xu, Shan Li, Qiongli Su, Jing Yan, Bo Liu, Ran Li
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2022)
Bladder cancer (BC) ranks the fourth in incidence in cancers of men and is a common malignant tumor in women. 4-Methoxydalbergione (4MOD), which is purified from Dalbergia sissoo Roxb, has been shown to have anticancer capacity for osteosarcoma and a
Externí odkaz:
https://doaj.org/article/ab83d00b1ca64a21b0f3da48f697683c
Autor:
Yanjun Huang, Sichun Zhou, Caimei He, Jun Deng, Ting Tao, Qiongli Su, Kwame Oteng Darko, Mei Peng, Xiaoping Yang
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-14 (2018)
Abstract Background In previous studies, we have shown that the combination of metformin and gefitinib inhibits the growth of bladder cancer cells. Here we examined whether the metformin analogue phenformin, either used alone or in combination with g
Externí odkaz:
https://doaj.org/article/d94918f555354fc1943f499ad88f4470
Autor:
Shiqi Ye, Meng Lv, Zhuo Chen, Qianbin Li, Gaoyun Hu, Zhijun Tu, Qiongli Su, Zutao Yu, Mengni Kuai, Rangru Liu, Xiaoping Yang, Hongbo Yuan
Publikováno v:
Bioorganic & Medicinal Chemistry. 27:944-954
The dysfunction and mutual compensatory activation of RAF-MEK-ERK and PI3K-PDK1-AKT pathways have been demonstrated as the hallmarks in several primary and recurrent cancers. The strategy of concurrent blocking of these two pathways shows clinical me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab69dcefb066b751ec2524430713ed7
https://doi.org/10.1016/j.bmc.2019.01.028
https://doi.org/10.1016/j.bmc.2019.01.028
Publikováno v:
Cancer Management and Research. 11:2405-2414
Clusterin is a conserved glycoprotein that has been characterized from almost all human tissues and fluids and plays a key role in cellular stress response and survival. Recently, research efforts have been contributed to explore the function of Clus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3cee3cd82b91fa1523362a3abcbfd49
https://doi.org/10.2147/cmar.s196273
https://doi.org/10.2147/cmar.s196273
Autor:
Qiongli Su, Shanping He, Kwame Oteng Darko, Qing Zeng, Sichun Zhou, Jun Deng, Lei Tang, Mei Peng, Alex F. Chen, Ting Tao, Xiaoping Yang
Publikováno v:
Journal of Cellular and Molecular Medicine
Pyruvate kinase M2 (PKM2) regulates the final step of glycolysis levels that are correlated with the sensitivity of anticancer chemotherapeutic drugs. THP is one of the major drugs used in non‐muscle‐invasive bladder cancer instillation chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9ce645c2e7e23ed4722d4a2a6b79df
https://doi.org/10.1111/jcmm.13571
https://doi.org/10.1111/jcmm.13571
Autor:
Qiongli Su, Ting Tao, Caimei He, Meiling Yi, Hui Zou, Mei Peng, Jun Deng, Kwame Oteng Darko, Xiaoping Yang, Yanjun Huang
Publikováno v:
Oncotarget. 8:71657-71671
// Ting Tao 1, 2 , Caimei He 1, 2 , Jun Deng 1, 2 , Yanjun Huang 1, 2 , Qiongli Su 1, 2 , Mei Peng 1, 2, 4 , Meiling Yi 1, 2 , Kwame Oteng Darko 1, 2 , Hui Zou 1, 2 and Xiaoping Yang 1, 2, 3 1 Key Laboratory of Small Targeted Molecules’ Discovery,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e096484de0a13f4e627d12c90b6f345
https://doi.org/10.18632/oncotarget.17799
https://doi.org/10.18632/oncotarget.17799
Autor:
Caimei He, Xiaoping Yang, Mei Peng, Zhao-Qian Liu, Kwame Oteng Darko, Ting Tao, Yanjun Huang, Tao Yin, Qiongli Su
Publikováno v:
Cancer Treatment Reviews. 54:24-33
Metformin, a widely prescribed drug for treating type II diabetes, is one of the most extensively recognized metabolic modulators which has shown an important anti-cancer property. However, fairly amount of clinical trials on its single administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9bd155d619f243772e2bb7abf6b71d
https://doi.org/10.1016/j.ctrv.2017.01.005
https://doi.org/10.1016/j.ctrv.2017.01.005
Autor:
Wei Ma, Gaosheng Xu, Qiongli Su, Jun Deng, Sichun Zhou, Xiaoping Yang, Zheng Sun, Ting Tao, Mei Peng, Shiyuan Wu
Publikováno v:
Bioscience Reports
Reprogrammed metabolism is an important hallmark of cancer cells. Pyruvate kinase (PK) is one of the major rate-limiting enzymes in glucose metabolism. The M2 isoform of PK (PKM2), is considered to be an important marker of metabolic reprogramming an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9748155e39185cf39522ec3e6e7dcf
http://europepmc.org/articles/PMC6851521
http://europepmc.org/articles/PMC6851521